2021 annual financial data
SAB Biotherapeutics 2021 Net margin
SAB Biotherapeutics 2021 net margin with verified reported values.
Direct answer
Net margin was -28.16%.
Operating income was -13,393,000 USD and net income was -17,145,000 USD.
Operating cash flow was 1,986,873 USD.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,876,000 USD
- Operating income
- -13,393,000 USD
- Net income
- -17,145,000 USD
- Operating cash flow
- 1,986,873 USD